Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc analysis of the PIONEER I and II ...

Bimekizumab effectively inhibits IL-17A and IL-17F, crucial cytokines in hidradenitis suppurativa, providing durable treatment outcomes. Over 85% of patients maintained their response to bimekizumab ...

Panelists discuss optimizing hidradenitis suppurativa management through early intervention, personalized treatment based on disease severity, and multidisciplinary coordination led by dermatologists ...

On April 4, 2024, the US Food and Drug Administration accepted a supplemental Biologics License Application (sBLA) to review bimekizumab-bkzx, an interleukin (IL)-17A and IL-17F inhibitor, for the ...

A big part of living with the skin condition known as hidradenitis suppurativa (also known as HS or acne inversa) is paying attention to details in your day-to-day life: What factors seem to make new ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition before—and so many people have not, even though HS is not actually rare (it ...

Whether it's cystic acne or psoriasis, managing a skin condition comes with its own set of challenges. One condition in particular that often goes undiagnosed is hidradenitis suppurativa (HS), which ...

Most skin diseases are unpleasant to live with, but hidradenitis suppurativa is one that can become much more than just uncomfortable and unattractive. While other skin conditions like acne, eczema, ...